Form 4: CareDx Director Michael Goldberg Receives Equity Grant as Compensation

CareDx, Inc. Director Michael Goldberg received an automatic quarterly grant of 1,218 shares of common stock as non-employee director compensation, increasing his total beneficial ownership to 154,216 shares.

Summary

• Michael Goldberg, a Director of CareDx, Inc. (CDNA), acquired common stock on July 8, 2025.
• The transaction involved the acquisition of 1,218 shares of common stock.
• The shares were acquired at a price of $0 per share, indicating a grant rather than a purchase.
• This acquisition represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation.
• The grant was made pursuant to CareDx, Inc.'s Outside Director Compensation Policy.
• Following this transaction, Michael Goldberg beneficially owns a total of 154,216 shares of CareDx, Inc. common stock.

Sentiment

Score: 7

Explanation: The filing reports a routine, pre-scheduled equity grant to a director as part of their compensation, which is a neutral event but positively aligns director interests with shareholders.

Positives

• Director Michael Goldberg's beneficial ownership increased by 1,218 shares, further aligning his interests with those of shareholders.
• The grant is part of a pre-established Outside Director Compensation Policy, indicating a structured and transparent approach to non-employee director compensation.

Negatives

• No direct negatives are apparent from this routine compensation grant.

Risks

• No specific risks are detailed in this Form 4 filing, as it primarily reports an insider transaction.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing, as it is a regulatory report of an insider transaction.

Management Comments

• No specific management comments or quotes are included in this Form 4 filing, which is a regulatory disclosure of an insider transaction.

Industry Context

This Form 4 filing reports a routine insider transaction (director compensation) and does not provide broader industry context or trends.

Comparison to Industry Standards

• Not applicable, as this Form 4 reports a standard insider compensation transaction rather than company performance metrics for industry comparison.

Management Changes

Corporate Governance

Legal Proceedings

• No legal proceedings or regulatory matters are disclosed in this Form 4 filing.

Related Party Transactions

• The acquisition of common stock by Director Michael Goldberg constitutes a related party transaction, as it is compensation provided by the issuer to an insider.

Stakeholder Impact

• Shareholders may view the equity grant to a director positively as it aligns the director's financial interests with the long-term performance of the company's stock.

Next Steps

• No specific future actions or milestones are detailed in this Form 4 filing.

Key Dates

Recommendation

Keywords

CareDx, CDNA, Michael Goldberg, Form 4, insider transaction, stock grant, director compensation, beneficial ownership, equity compensation